ID: MRFR/Pharma/4960-HCR | 90 Pages | Author: Rahul Gotadki | December 2023
Mouth ulcer treatment market is expected to register USD 1.13 Billion by 2030, at a CAGR of 3.90% during the forecast period
$1.13 Billion
3.90%
North America
2022-2030
Segmentation
The mouth ulcer treatment market has been segmented on basis of drug type, formulation, and indication. On basis of drug type, the market is segmented into corticosteroid, antihistamine, antimicrobial, analgesic, and anesthetic. Based on formulation, the market is segmented into gel, mouthwash, ointment, spray, and lozenges. Based on indication market is segmented into Aphthous Stomatitis, Oral Lichen Planus and Others.
Key players
Key players in the mouth ulcer treatment market are Pfizer, Inc., Church & Dwight Co., Inc., 3M, Taro Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, BLISTEX, INC., GlaxoSmithKline plc., ECR Pharmaceuticals, Sannova, Reckitt Benckiser, Sunstar, Blairex Laboratories, Sanjin Pharmaceutical, Joincare Pharmaceutical, Sinclair Pharma, Colgate-Palmolive Company
Regional Market Summary
Global Mouth Ulcer Treatment Market Share (%), by Region, 2018
Source: World Health Organization (WHO)
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The mouth ulcer treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The mouth ulcer treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.
Manx Healthcare introduced Oral Soothe and Sore Throat 0.15 percent w/v mouthwash in September 2021, an over-the-counter product used to treat mouth and throat pain caused by a variety of medical issues, such as dental surgery, tonsillitis, gum disease, mouth ulcers, and other mouth and throat conditions.
GELX ORAL GEL, a Zinc-Taurine bioactive barrier therapy for the management and reduction of oral discomfort associated with oral mucositis, was launched in May 2020 by US WorldMeds, LLC.
Market of Mouth Ulcer Treatment, by Drug Type
Market of Mouth Ulcer Treatment, by Formulation
Market of Mouth Ulcer Treatment, by Indications
Market of Mouth Ulcer Treatment, by Region
Americas
Europe
Asia-Pacific
Middle East & Africa
Report Attribute/Metric | Details |
Market Size | 2030: USD 1.13 Billion |
CAGR | 2022-2030: 3.90% |
Base Year | 2022 |
Forecast Period | 2030 |
Historical Data | 2018 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Drug Type, Formulation, and Indication |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Pfizer, Inc., Church & Dwight Co., Inc., 3M, Taro Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, BLISTEX, INC., GlaxoSmithKline plc., ECR Pharmaceuticals, Sannova, Reckitt Benckiser, Sunstar, Blairex Laboratories, Sanjin Pharmaceutical, Joincare Pharmaceutical, Sinclair Pharma, Colgate-Palmolive Company |
Key Market Opportunities | · Growing awareness among consumers regarding the availability of mouth ulcer treatment is the key share to increase the growth of the market in North America · increasing incidences of an aging population suffering from mouth in Europe |
Key Market Drivers | · Increasing use of synthetics in oral items such as toothpaste · Growing unhealthy lifestyle, including high consumption of junk food and tobacco |
Casual approach taken by most patients towards mouth ulcers is the key restraint on the market, as this stops patients from seeking out recognized medication.
Mouth Ulcer Treatment Market is expected to exhibit a steady 3.90% CAGR over the forecast period from 2022 to 2030.
Growing prevalence of mouth ulcers is likely to be a major driver for the market.
Americas hold the largest share in the global mouth ulcer treatment market.
Leading players in the Mouth Ulcer Treatment Market include BLISTEX Inc., 3M, and Pfizer, among others.
Key Questions Answered
Why Choose Market Research Future?